10-K: FitLife Brands Reports 26% Revenue Growth Driven by Irwin Acquisition

FitLife Brands, Inc. announced a 26% increase in annual revenue to $81.46 million for fiscal year 2025, primarily fueled by the acquisition of Irwin Naturals, despite a decline in net income and gross margin.

Summary

• Total revenue for the year ended December 31, 2025, increased by 26% to $81.46 million, up from $64.47 million in 2024.
• The increase in revenue was primarily driven by the acquisition of Irwin Naturals on August 8, 2025, which contributed $19.47 million in revenue from the acquisition date through year-end.
• Net income decreased by 30% to $6.33 million in 2025, compared to $8.98 million in 2024.
• Gross profit increased by 12% to $31.45 million in 2025, but gross margin decreased to 38.6% from 43.6% in 2024, largely due to the lower gross margin profile of Irwin and amortization of inventory step-up.
• Operating income declined by 23% to $10.06 million in 2025, down from $13.12 million in 2024.
• Legacy FitLife brands experienced a 4% revenue decrease to $61.99 million in 2025, with online revenue down 7% and wholesale revenue up 2%.
• The company completed a 2-for-1 stock split of its Common Stock on February 7, 2025.
• Total debt increased significantly to $44.54 million as of December 31, 2025, primarily due to the $40.63 million Irwin Term Loan and a $5.60 million revolving line of credit used for the acquisition and refinancing existing debt.
• Working capital improved to $11.46 million at year-end 2025, up from $6.83 million in 2024, mainly due to higher accounts receivable and inventory from the Irwin acquisition.
• Cash and cash equivalents decreased to $1.65 million at year-end 2025 from $4.47 million in 2024.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with cautious optimism. While the significant revenue growth from the Irwin acquisition is positive for scale, the notable decline in net income and gross margin, coupled with increased debt and a decrease in Legacy FitLife revenue, indicates integration challenges and potential profitability pressures.

Positives

• Total revenue increased by a significant 26% year-over-year, reaching $81.46 million, primarily due to the strategic acquisition of Irwin Naturals.
• The acquisition of Irwin Naturals successfully diversified the company's product offerings and distribution channels, adding strength in mass market and health food store segments.
• Working capital improved to $11.46 million, indicating a stronger short-term financial position.
• The company successfully secured new financing arrangements, including a $40.63 million term loan and a $10.00 million revolving line of credit, to fund the Irwin acquisition and refinance existing debt.
• Online sales of Irwin products on Amazon, which were minimal prior to acquisition, grew to approximately $0.5 million in December 2025, demonstrating successful integration and expansion into e-commerce for the acquired brand.
• The company maintains a robust cybersecurity risk management framework, utilizing third-party experts and quarterly Audit Committee evaluations, with no material threats identified to date.

Negatives

• Net income decreased by 30% to $6.33 million in 2025, compared to $8.98 million in 2024, despite higher revenue.
• Gross margin declined to 38.6% in 2025 from 43.6% in 2024, primarily due to the lower gross margin profile of Irwin Naturals and a $1.05 million amortization of inventory step-up.
• Operating income decreased by 23% to $10.06 million in 2025.
• Legacy FitLife brands experienced a 4% revenue decrease, with online revenue for these brands declining by 7%.
• Merger and acquisition related expenses significantly increased to $2.08 million in 2025 from $0.26 million in 2024, impacting profitability.
• Cash and cash equivalents decreased by $2.82 million, from $4.47 million in 2024 to $1.65 million in 2025.
• The company incurred substantial new debt, totaling $44.54 million as of December 31, 2025, which increases financial leverage and interest expense.

Risks

• Significant competition in the nutrition industry from numerous resellers, manufacturers, and wholesalers, many with greater financial resources and established brands.
• Substantial portion of revenue (49% in 2025) is from Amazon's U.S. marketplace, making the company vulnerable to changes in Amazon's terms of service, policies, or platform changes.
• Dependence on GNC for a substantial portion of sales (14% in 2025), with GNC franchisees not required to carry products and GNC's past bankruptcy impacting receivables.
• Risk of loss or significant reduction of purchases by major distribution partners or customers, which could materially affect revenue and cash flows.
• Inability to successfully increase sales to wholesale partners and directly to end consumers through e-commerce platforms.
• Failure to identify and adapt to changing consumer and customer preferences and behaviors, including dietary trends, health concerns, and preferred sales channels.
• Inability to protect intellectual property rights (trademarks, trade secrets, know-how, copyrights) could reduce brand value and competitiveness.
• Adverse publicity or negative consumer perceptions of brands, products, or the nutritional supplement industry could significantly diminish brand value and sales.
• Dependence on a limited number of independent suppliers and manufacturers, which could lead to supply interruptions, delays, or quality issues.
• Adverse publicity associated with products or ingredients, or claims of ineffectiveness, inappropriate labeling, or harmful side effects, could reduce market demand.
• Limited conclusive clinical studies supporting the efficacy of nutritional supplement products, potentially leading to reduced market acceptance.
• A slower growth rate in the nutritional supplement industry could negatively impact demand for products and revenue growth.
• Future outbreaks of COVID-19 or other illnesses could adversely affect operations, supply chains, and wholesale partners.
• Dependence on the experience and skill of the Chief Executive Officer and key personnel, with no assurance of retention or ability to hire additional personnel.
• Potential requirement to obtain an auditor attestation on internal control over financial reporting if the company becomes an accelerated filer, leading to increased costs and resource demands.
• Failure to achieve sustained profitability or effectively manage growth could result in future net losses.
• Unfavorable economic conditions, including high inflation and recessions, may reduce consumer discretionary spending and impact sales.
• Changes in trade policies, treaties, and tariffs, particularly with countries like China, Mexico, and Canada, could increase raw material costs.
• Substantial debt incurred from acquisitions ($44.7 million as of December 31, 2025) could limit future financing, make debt servicing difficult, and increase vulnerability to adverse economic conditions.
• Covenants in financing arrangements (e.g., Senior Funded Debt to EBITDA Ratio, Fixed Charge Coverage Ratio) could restrict business operations and lead to default if not met.
• Inability to generate sufficient cash flow from operations to service debt obligations and fund other liquidity needs.
• Increases in variable interest rates could negatively affect earnings and cash flows due to outstanding variable-rate debt.
• Impairment in the carrying value of intangible assets (goodwill, trademarks, customer relationships) could result in significant charges to financial condition and results of operations.
• Unsuccessful implementation of business strategies to reduce costs or unintended consequences of such strategies may adversely affect financial performance.
• Extensive and evolving laws, governmental regulations, and administrative determinations in the U.S. and internationally can lead to costly compliance and potential enforcement actions.
• Errors in product manufacturing by third-party manufacturers could result in product recalls, legal exposure, and reduced revenue.
• Higher regulatory scrutiny for certain products (e.g., dietary supplements) results in increased operational costs and potential delays in product sales.
• Pending and future litigation and claims, including product liability and deceptive advertising, could impair reputation or lead to significant costs.
• Products not meeting health and safety standards or becoming contaminated could lead to recalls, liability claims, and negative publicity.
• Risks associated with potential future acquisitions, including inability to consummate favorable transactions or successfully integrate acquired businesses.
• Failure to comply with Nasdaq Capital Market continued listing requirements could result in delisting and negatively impact stock price and access to capital markets.
• The market price of the company's securities could be subject to wide fluctuations.
• The potential issuance of Preferred Stock with rights senior to Common Stock could dilute the value or rights of common shareholders.
• No cash dividends are anticipated on Common Stock in the foreseeable future.
• Concentration of ownership by the CEO and a significant shareholder (Sudbury Capital Fund, LP) could influence matters requiring stockholder approval and potentially delay or prevent a change in control.

Future Outlook

The company anticipates that cash derived from operations, existing cash reserves, and available borrowings under the line of credit will be sufficient to provide liquidity for the next twelve months. Management expects the percentage of sales to GNC to continue to decrease in the fiscal year ending December 31, 2026, due to the full-year recognition of sales attributable to the Irwin brands. The company also plans to continue assessing and analyzing developing market trends to introduce new products and packaging solutions.

Management Comments

• Management believes that contribution, as defined by the Company, is a particularly relevant performance metric since it incorporates the gross profit associated with a specific brand or collection of brands as well as the advertising and marketing expenditures associated with the same brand or brands.
• Management is committed to work collaboratively with GNC and its franchisees to build on our established track record of innovation and operational performance.
• Management continually assesses and analyzes developing market trends to detect and proactively address what they believe are areas of unmet or growing demand that represent an opportunity for the Company and, where deemed appropriate, attempts to introduce new products and/or packaging solutions in direct response to meet that demand.
• We consider our employee relations to be good.

Industry Context

StockSavvy.ai notes that FitLife Brands operates in a highly competitive nutrition industry, which is driven by increasing consumer awareness of diet-health connections, an aging population, rising healthcare costs favoring preventative medicine, and new product introductions based on scientific studies. The company's strategy of acquiring established brands like Irwin Naturals and expanding e-commerce presence for these brands aligns with broader industry trends of consolidation and a shift towards online retail, as consumers increasingly shop through e-commerce websites and mobile applications. However, the industry also faces challenges from evolving consumer preferences, intense competition, and regulatory scrutiny, which FitLife Brands must navigate effectively.

Comparison to Industry Standards

• The decline in gross margin to 38.6% for FitLife Brands in 2025, partly due to the acquisition of Irwin Naturals which historically generated lower gross margins, suggests that the acquired portfolio may operate at a lower profitability level compared to some industry peers focused on premium or niche products. For instance, companies like Herbalife Nutrition (HLF) or GNC Holdings (GNC) often report varying gross margins depending on their product mix and distribution models, with some direct-selling or specialty retail models potentially achieving higher margins on proprietary blends.
• The significant increase in total debt to $44.54 million following the Irwin acquisition, while common for growth-by-acquisition strategies, positions FitLife Brands with higher leverage compared to some more organically growing or cash-rich competitors in the wellness space. For example, larger consumer health companies like Nestle Health Science or Unilever's health and wellbeing division might have lower debt-to-equity ratios due to their broader financial bases and diversified revenue streams.
• The company's dependence on Amazon for 49% of its total sales in 2025 highlights a concentration risk that is higher than many diversified consumer goods companies. While Amazon provides significant reach, it also exposes FitLife Brands to platform policy changes and fee increases, a risk that companies with more balanced multi-channel distribution (e.g., direct-to-consumer, specialty retail, mass market, international) might mitigate more effectively.

Corporate Governance

Legal Proceedings

• The company is not currently involved in any litigation that is believed to have a material adverse effect on its financial condition or results of operations.

Related Party Transactions

• Dayton Judd, the company's Chair and Chief Executive Officer, along with Sudbury Capital Fund, LP, may be deemed beneficial owners of a majority of the company's outstanding voting securities, allowing them to significantly influence matters requiring stockholder approval.

Stakeholder Impact

• Shareholders: Experience diluted net income per share and increased debt, but also significant revenue growth and strategic expansion through acquisition. The stock split and share repurchase program extension could impact share liquidity and value.
• Employees: The workforce increased significantly from 39 to 81 full-time employees, primarily due to the Irwin acquisition, indicating job creation and expanded operational scope.
• Customers: Benefit from a diversified product portfolio, including the addition of Irwin Naturals brands, and expanded distribution channels, particularly online.
• Suppliers: The company's dependence on a limited number of third-party suppliers and manufacturers means these suppliers are critical to operations, but also face risks if the company changes suppliers or experiences supply chain disruptions.
• Creditors: The new credit agreement with First-Citizens Bank & Trust Company provides significant debt financing, making the bank a key creditor with specific financial covenants to be met.

Next Steps

• Continue to integrate Irwin Naturals' operations and brands, including expanding online sales through Amazon and other e-commerce platforms.
• Monitor and manage compliance with financial covenants related to the new credit agreement, specifically the Senior Funded Debt to EBITDA Ratio and Fixed Charge Coverage Ratio.
• Evaluate and potentially engage in foreign currency hedging transactions as the geographical scope of the business broadens.
• Continue to assess and analyze developing market trends to reformulate existing products and introduce new products and/or packaging solutions.
• Management will continue to provide supplemental disclosure on the performance of acquired brands for up to two years post-acquisition, after which they will be reported as part of Legacy FitLife results.

Key Dates

Recommendation

The filing presents a mixed bag of results. While the 26% revenue growth driven by the Irwin Naturals acquisition is a positive indicator of strategic expansion and market presence, the significant 30% decline in net income and a 500 basis point drop in gross margin raise concerns about profitability and integration efficiency. The substantial increase in debt to fund the acquisition also introduces higher financial risk. The core Legacy FitLife business showing a 4% revenue decrease suggests underlying challenges that the acquisition is masking. Given the strong top-line growth offset by profitability pressures and increased leverage, a 'hold' recommendation is appropriate. Investors should monitor the successful integration of Irwin Naturals, the realization of anticipated synergies, and the company's ability to improve gross margins and net income in future periods, especially as the impact of inventory step-up amortization diminishes and the Legacy FitLife segment stabilizes.

Keywords

Nutritional Supplements, Wellness Products, SEC Filing, 10-K, FitLife Brands, FTLF, Irwin Naturals Acquisition, Financial Performance, Revenue Growth, Net Income Decline, Gross Margin, Debt Financing, E-commerce Sales, Amazon Marketplace, GNC Distribution, Corporate Governance, Risk Factors, Stock Split, Share Repurchase Program, Cybersecurity, Dietary Supplements